Global and United States Xeloda Market Report & Forecast 2024-2031

Report ID: 1845587 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Xeloda Product Introduction
    1.2 Global Xeloda Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Xeloda Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Xeloda Sales in Volume for the Year 2017-2028
    1.3 United States Xeloda Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Xeloda Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Xeloda Sales in Volume for the Year 2017-2028
    1.4 Xeloda Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Xeloda in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Xeloda Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Xeloda Market Dynamics
        1.5.1 Xeloda Industry Trends
        1.5.2 Xeloda Market Drivers
        1.5.3 Xeloda Market Challenges
        1.5.4 Xeloda Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Xeloda Market Segment by Type
        2.1.1 500 mg
        2.1.2 150 mg
    2.2 Global Xeloda Market Size by Type
        2.2.1 Global Xeloda Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Xeloda Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Xeloda Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Xeloda Market Size by Type
        2.3.1 United States Xeloda Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Xeloda Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Xeloda Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Xeloda Market Segment by Application
        3.1.1 Breast Cancer
        3.1.2 Colorectal cancer
        3.1.3 Stomach Cancer
    3.2 Global Xeloda Market Size by Application
        3.2.1 Global Xeloda Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Xeloda Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Xeloda Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Xeloda Market Size by Application
        3.3.1 United States Xeloda Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Xeloda Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Xeloda Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Xeloda Competitor Landscape by Company
    4.1 Global Xeloda Market Size by Company
        4.1.1 Top Global Xeloda Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Xeloda Revenue by Manufacturer (2017-2022)
        4.1.3 Global Xeloda Sales by Manufacturer (2017-2022)
        4.1.4 Global Xeloda Price by Manufacturer (2017-2022)
    4.2 Global Xeloda Concentration Ratio (CR)
        4.2.1 Xeloda Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Xeloda in 2021
        4.2.3 Global Xeloda Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Xeloda Manufacturing Base Distribution, Product Type
        4.3.1 Global Xeloda Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Xeloda Product Type
        4.3.3 Date of International Manufacturers Enter into Xeloda Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Xeloda Market Size by Company
        4.5.1 Top Xeloda Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Xeloda Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Xeloda Sales by Players (2020, 2021 & 2022)
5 Global Xeloda Market Size by Region
    5.1 Global Xeloda Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Xeloda Market Size in Volume by Region (2017-2028)
        5.2.1 Global Xeloda Sales in Volume by Region: 2017-2022
        5.2.2 Global Xeloda Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Xeloda Market Size in Value by Region (2017-2028)
        5.3.1 Global Xeloda Sales in Value by Region: 2017-2022
        5.3.2 Global Xeloda Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Xeloda Market Size YoY Growth 2017-2028
        6.1.2 North America Xeloda Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Xeloda Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Xeloda Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe Xeloda Market Size YoY Growth 2017-2028
        6.3.2 Europe Xeloda Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Xeloda Market Size YoY Growth 2017-2028
        6.4.2 Latin America Xeloda Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Brazil
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Xeloda Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Xeloda Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 GCC Countries
        6.5.5 Egypt
        6.5.6 South Africa
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Corporation Information
        7.1.2 Roche Description and Business Overview
        7.1.3 Roche Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Roche Xeloda Products Offered
        7.1.5 Roche Recent Development
    7.2 Teva
        7.2.1 Teva Corporation Information
        7.2.2 Teva Description and Business Overview
        7.2.3 Teva Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Teva Xeloda Products Offered
        7.2.5 Teva Recent Development
    7.3 Mylan
        7.3.1 Mylan Corporation Information
        7.3.2 Mylan Description and Business Overview
        7.3.3 Mylan Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Mylan Xeloda Products Offered
        7.3.5 Mylan Recent Development
    7.4 Hikma
        7.4.1 Hikma Corporation Information
        7.4.2 Hikma Description and Business Overview
        7.4.3 Hikma Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Hikma Xeloda Products Offered
        7.4.5 Hikma Recent Development
    7.5 Hengrui Medicine
        7.5.1 Hengrui Medicine Corporation Information
        7.5.2 Hengrui Medicine Description and Business Overview
        7.5.3 Hengrui Medicine Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Hengrui Medicine Xeloda Products Offered
        7.5.5 Hengrui Medicine Recent Development
    7.6 Cipla
        7.6.1 Cipla Corporation Information
        7.6.2 Cipla Description and Business Overview
        7.6.3 Cipla Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Cipla Xeloda Products Offered
        7.6.5 Cipla Recent Development
    7.7 Reliance Group
        7.7.1 Reliance Group Corporation Information
        7.7.2 Reliance Group Description and Business Overview
        7.7.3 Reliance Group Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Reliance Group Xeloda Products Offered
        7.7.5 Reliance Group Recent Development
    7.8 Hetero
        7.8.1 Hetero Corporation Information
        7.8.2 Hetero Description and Business Overview
        7.8.3 Hetero Xeloda Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Hetero Xeloda Products Offered
        7.8.5 Hetero Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Xeloda Industry Chain Analysis
    8.2 Xeloda Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Xeloda Distributors
    8.3 Xeloda Production Mode & Process
    8.4 Xeloda Sales and Marketing
        8.4.1 Xeloda Sales Channels
        8.4.2 Xeloda Distributors
    8.5 Xeloda Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Xeloda CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Xeloda Market Trends
    Table 3. Xeloda Market Drivers
    Table 4. Xeloda Market Challenges
    Table 5. Xeloda Market Restraints
    Table 6. Global Xeloda Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Xeloda Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Xeloda Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Xeloda Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Xeloda Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Xeloda Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Xeloda Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Xeloda Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Xeloda Sales Share by Manufacturer, 2017-2022
    Table 15. Global Xeloda Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Xeloda Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Xeloda by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xeloda as of 2021)
    Table 18. Top Players of Xeloda in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Xeloda Product Type
    Table 20. Date of International Manufacturers Enter into Xeloda Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Xeloda Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Xeloda Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Xeloda Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Xeloda Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Xeloda Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Xeloda Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Xeloda Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Xeloda Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Xeloda Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Xeloda Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Xeloda Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Xeloda Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Xeloda Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Xeloda Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Xeloda Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Xeloda Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Xeloda Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Xeloda Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Xeloda Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Xeloda Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Roche Xeloda Product
    Table 46. Roche Recent Development
    Table 47. Teva Corporation Information
    Table 48. Teva Description and Business Overview
    Table 49. Teva Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Teva Product
    Table 51. Teva Recent Development
    Table 52. Mylan Corporation Information
    Table 53. Mylan Description and Business Overview
    Table 54. Mylan Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Mylan Product
    Table 56. Mylan Recent Development
    Table 57. Hikma Corporation Information
    Table 58. Hikma Description and Business Overview
    Table 59. Hikma Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Hikma Product
    Table 61. Hikma Recent Development
    Table 62. Hengrui Medicine Corporation Information
    Table 63. Hengrui Medicine Description and Business Overview
    Table 64. Hengrui Medicine Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Hengrui Medicine Product
    Table 66. Hengrui Medicine Recent Development
    Table 67. Cipla Corporation Information
    Table 68. Cipla Description and Business Overview
    Table 69. Cipla Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Cipla Product
    Table 71. Cipla Recent Development
    Table 72. Reliance Group Corporation Information
    Table 73. Reliance Group Description and Business Overview
    Table 74. Reliance Group Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Reliance Group Product
    Table 76. Reliance Group Recent Development
    Table 77. Hetero Corporation Information
    Table 78. Hetero Description and Business Overview
    Table 79. Hetero Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Hetero Product
    Table 81. Hetero Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Xeloda Customers List
    Table 85. Xeloda Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Xeloda Product Picture
    Figure 2. Global Xeloda Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Xeloda Market Size 2017-2028 (US$ Million)
    Figure 4. Global Xeloda Sales 2017-2028 (K MT)
    Figure 5. United States Xeloda Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Xeloda Market Size 2017-2028 (US$ Million)
    Figure 7. United States Xeloda Sales 2017-2028 (K MT)
    Figure 8. United States Xeloda Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Xeloda Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Xeloda Report Years Considered
    Figure 11. Product Picture of 500 mg
    Figure 12. Product Picture of 150 mg
    Figure 13. Global Xeloda Market Share by Type in 2022 & 2028
    Figure 14. Global Xeloda Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Xeloda Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Xeloda Sales by Type (2017-2028) & (K MT)
    Figure 17. Global Xeloda Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Xeloda Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Xeloda Market Share by Type in 2022 & 2028
    Figure 20. United States Xeloda Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Xeloda Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Xeloda Sales by Type (2017-2028) & (K MT)
    Figure 23. United States Xeloda Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Xeloda Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Breast Cancer
    Figure 26. Product Picture of Colorectal cancer
    Figure 27. Product Picture of Stomach Cancer
    Figure 28. Global Xeloda Market Share by Application in 2022 & 2028
    Figure 29. Global Xeloda Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Xeloda Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Xeloda Sales by Application (2017-2028) & (K MT)
    Figure 32. Global Xeloda Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Xeloda Price by Application (2017-2028) & (USD/MT)
    Figure 34. United States Xeloda Market Share by Application in 2022 & 2028
    Figure 35. United States Xeloda Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Xeloda Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Xeloda Sales by Application (2017-2028) & (K MT)
    Figure 38. United States Xeloda Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Xeloda Price by Application (2017-2028) & (USD/MT)
    Figure 40. North America Xeloda Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 41. North America Xeloda Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Mexico Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Xeloda Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 46. Europe Xeloda Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. UK Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Xeloda Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 53. Asia-Pacific Xeloda Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Vietnam Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Xeloda Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 65. Latin America Xeloda Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Brazil Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Xeloda Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 68. Middle East & Africa Xeloda Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. GCC Countries Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Egypt Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. South Africa Xeloda Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Xeloda Value Chain
    Figure 74. Xeloda Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Frequently Asked Questions
Xeloda report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Xeloda report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Xeloda report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Analog Clock

Analog Clock market is segmented by region (country), players, by Type and by Application. Player ... Read More